Nasal airway treatment worth it in sleep apnoea syndrome?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.411, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Screening for obstructive sleep apnoea after stroke worth the cost?

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Dihydroquinidine: potential for treatment of short-QT syndrome?

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

New treatments for Tourette's syndrome?

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pharmacotherapies for Obstructive Sleep Apnoea: Where Are We Now?

By Smith I.E. Quinnell T.G.

Drugs, Vol. 64, Iss. 13, 2004-01 ,pp. : 1385-1399

Adis International

Access to resources Recommend Favorite

Reassessing the Benefits and Risks of Alosetron: What is its Place in the Treatment of Irritable Bowel Syndrome?

By Andresen V.

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 283-292

Adis International

Access to resources Recommend Favorite